U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C18H39NO3
Molecular Weight 317.5072
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PHYTOSPHINGOSINE

SMILES

CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@@H](N)CO

InChI

InChIKey=AERBNCYCJBRYDG-KSZLIROESA-N
InChI=1S/C18H39NO3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-17(21)18(22)16(19)15-20/h16-18,20-22H,2-15,19H2,1H3/t16-,17+,18-/m0/s1

HIDE SMILES / InChI
Phytosphingosine is structural analog of sphingolipids and is classified as long-chain sphingoid base. Phytosphingosine significantly induced chromatin DNA fragmentation. Phytosphingosine caused strong induction of caspase-8 activity and caspase-independent Bax translocation to the mitochondria. It shows excellent clinical results in the context of skin care in acne, based on both anti-inflammatory and anti-microbial activity. Phytosphingosine is currently seen in a variety of products as a skin and hair conditioning agent. Phytosphingosine might serve as an effective melanogenesis inhibitor in melanocytes via the regulation of the MITF signaling pathways. Dietary supplementation of phytosphingosine decreases plasma cholesterol levels and enhances insulin sensitivity in men with the metabolic syndrome.

Originator

Sources: DOI: 10.1007/BF01519846
Curator's Comment: Cerebrin base was iirst isolated from mushrooms by Zellner and later from yeast by Reindel. Carter et al. isolated a long-chain base from corn phosphatide and showed it to be identical to cerebrin base. Its structure was established as 1,3,4-trihydroxy-2-aminooctadecane and it was named phytosphingosine. https://www.ncbi.nlm.nih.gov/pubmed/14018956

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Inactive ingredient
CheryLee MD TrueLipids Relieve and Protect Ointment

Approved Use

Uses: helps relieve, prevent and temporarily protect chafed, chapped, cracked or windburned skin and lips temporarily protects minor: cuts scrapes burns helps protect from the drying effects of wind and cold weather
PubMed

PubMed

TitleDatePubMed
Functional characterization of sphingolipid C4-hydroxylase genes from Arabidopsis thaliana.
2001 Apr 6
C26-CoA-dependent ceramide synthesis of Saccharomyces cerevisiae is operated by Lag1p and Lac1p.
2001 Jun 1
Role for de novo sphingoid base biosynthesis in the heat-induced transient cell cycle arrest of Saccharomyces cerevisiae.
2001 Mar 16
Dependence of the sphingoid bases concentration on growth phase and temperature in the yeast Yarrowia lipolytica.
2002
Simultaneous quantitative analysis of sphingoid base 1-phosphates in biological samples by o-phthalaldehyde precolumn derivatization after dephosphorylation with alkaline phosphatase.
2002 Apr 15
Human epidermal glucosylceramides are major precursors of stratum corneum ceramides.
2002 Aug
[Experimental survey of a new topical anti-oxidant based on furfuryl palmitate in the treatment of child's and baby's dermatitis with eczema: results from a multicenter clinical investigation].
2002 Oct
Suppression of extracellular signal-related kinase and activation of p38 MAPK are two critical events leading to caspase-8- and mitochondria-mediated cell death in phytosphingosine-treated human cancer cells.
2003 Dec 12
Induction of apoptosis and expression of cell cycle regulatory proteins in response to a phytosphingosine derivative in HaCaT human keratinocyte cells.
2003 Dec 31
Metabolomic profiling of sphingolipids in human glioma cell lines by liquid chromatography tandem mass spectrometry.
2003 Jul
Synthesis of 4-hydroxysphinganine and characterization of sphinganine hydroxylase activity in corn.
2003 Jul 15
The mitochondria-associated endoplasmic-reticulum subcompartment (MAM fraction) of rat liver contains highly active sphingolipid-specific glycosyltransferases.
2003 May 1
Tetraacetyl phytosphingosine-induced caspase activation and apoptosis occur through G2 arrest in human keratinocyte HaCaT cells.
2003 Nov
Alteration of the 4-sphingenine scaffolds of ceramides in keratinocyte-specific Arnt-deficient mice affects skin barrier function.
2003 Nov
Induction of apoptosis in cultured human proximal tubule cells by fumonisins and fumonisin metabolites.
2003 Oct 15
Distribution of sphingosine kinase activity in mouse tissues: contribution of SPHK1.
2003 Sep 12
Carbohydrate recognition by enterohemorrhagic Escherichia coli: characterization of a novel glycosphingolipid from cat small intestine.
2004 Feb
Structure and biological functions of fungal cerebrosides.
2004 Mar
Anti-ulcer actions of phytosphingosine hydrochloride in different experimental rat ulcer models.
2005
A novel coaxial electrospray ionization method for characterizing hexacosanoylceramides by Fourier transform ion cyclotron resonance mass spectrometry.
2005
Lipid mixtures prepared with well-defined synthetic ceramides closely mimic the unique stratum corneum lipid phase behavior.
2005 Dec
Phosphorylation of sphingoid long-chain bases in Arabidopsis: functional characterization and expression of the first sphingoid long-chain base Kinase gene in plants.
2005 Feb
Arabidopsis sphingosine kinase and the effects of phytosphingosine-1-phosphate on stomatal aperture.
2005 Feb
Phytosphingosine in combination with ionizing radiation enhances apoptotic cell death in radiation-resistant cancer cells through ROS-dependent and -independent AIF release.
2005 Feb 15
The sphingoid long chain base phytosphingosine activates AGC-type protein kinases in Saccharomyces cerevisiae including Ypk1, Ypk2, and Sch9.
2005 Jun 17
FTIR spectroscopic studies of lipid dynamics in phytosphingosine ceramide models of the stratum corneum lipid matrix.
2005 Mar
Design of a phytosphingosine-containing, positively-charged nanoemulsion as a colloidal carrier system for dermal application of ceramides.
2005 May
Inositol phosphoceramide synthase is a regulator of intracellular levels of diacylglycerol and ceramide during the G1 to S transition in Saccharomyces cerevisiae.
2005 May 15
Candida albicans serotype B strains synthesize a serotype-specific phospholipomannan overexpressing a beta-1,2-linked mannotriose.
2005 Nov
Regulation of the sphingoid long-chain base kinase Lcb4p by ergosterol and heme: studies in phytosphingosine-resistant mutants.
2005 Nov 4
APP1 transcription is regulated by inositol-phosphorylceramide synthase 1-diacylglycerol pathway and is controlled by ATF2 transcription factor in Cryptococcus neoformans.
2005 Oct 28
Structure-activity relationships of dimethylsphingosine (DMS) derivatives and their effects on intracellular pH and Ca2+ in the U937 monocyte cell line.
2006 Aug
Biophysics of sphingolipids I. Membrane properties of sphingosine, ceramides and other simple sphingolipids.
2006 Dec
Effect of lipid-containing, positively charged nanoemulsions on skin hydration, elasticity and erythema--an in vivo study.
2006 Jan 13
Phytosphingosine stimulates the differentiation of human keratinocytes and inhibits TPA-induced inflammatory epidermal hyperplasia in hairless mouse skin.
2006 Jan-Mar
An efficient high-yield synthesis of D-ribo-phytosphingosine.
2006 Jul 20
A general, efficient and stereospecific route to sphingosine, sphinganines, phytosphingosines and their analogs.
2006 Mar 21
Efficient synthesis of D-erythro-sphingosine and D-erythro-azidosphingosine from D-ribo-phytosphingosine via a cyclic sulfate intermediate.
2006 Oct 27
Constituents of Holothuroidea, 18. Isolation and structure of biologically active disialo- and trisialo-gangliosides from the sea cucumber Cucumaria echinata.
2006 Sep
Combination treatment with arsenic trioxide and phytosphingosine enhances apoptotic cell death in arsenic trioxide-resistant cancer cells.
2007 Jan
Phytosphingosine in combination with TRAIL sensitizes cancer cells to TRAIL through synergistic up-regulation of DR4 and DR5.
2007 Jan
Patents

Sample Use Guides

500 mg twice daily for a 4 weeks
Route of Administration: Oral
Jurkat and NCI-H460 cells were treated with 5 or 10 ug/ml phytosphingosine, respectively, for the 2, 5, 10, 30, 60, 120 min. phytosphingosine treatment led to a dramatic down-regulation of phosphorylated ERK1/2. The phosphorylated ERK started to diminish within 2 min of the phytosphingosine treatment.
Name Type Language
PHYTOSPHINGOSINE
INCI  
INCI  
Official Name English
D-RIBO-1,3,4-TRIHYDROXY-2-AMINOOCTADECANE
Common Name English
1,3,4-OCTADECANETRIOL, 2-AMINO-, (2S-(2R*,3R*,4S*))-
Common Name English
1,3,4-OCTADECANETRIOL, 2-AMINO-, D-RIBO-
Common Name English
D-RIBO-PHYTOSPHINGOSINE
Common Name English
DS-PHYTOSPHINGOSINE
Brand Name English
1,3,4-OCTADECANETRIOL, 2-AMINO-, (2S,3S,4R)-
Systematic Name English
(+)-D-RIBO-PHYTOSPHINGOSINE
Common Name English
C18-PHYTOSPHINGOSINE
Common Name English
CYTOMIDE PGS
Brand Name English
BIOMIDE PS
Brand Name English
SPHINGANINE, 4-D-HYDROXY
Common Name English
PHYTOSPHINGOSINE [INCI]
Common Name English
Phytosphingosine [WHO-DD]
Common Name English
4-D-HYDROXYSPHINGANINE
Common Name English
Code System Code Type Description
DRUG BANK
DB14119
Created by admin on Fri Dec 15 20:03:47 GMT 2023 , Edited by admin on Fri Dec 15 20:03:47 GMT 2023
PRIMARY
WIKIPEDIA
Phytosphingosine
Created by admin on Fri Dec 15 20:03:47 GMT 2023 , Edited by admin on Fri Dec 15 20:03:47 GMT 2023
PRIMARY
CHEBI
46961
Created by admin on Fri Dec 15 20:03:47 GMT 2023 , Edited by admin on Fri Dec 15 20:03:47 GMT 2023
PRIMARY
PUBCHEM
122121
Created by admin on Fri Dec 15 20:03:47 GMT 2023 , Edited by admin on Fri Dec 15 20:03:47 GMT 2023
PRIMARY
SMS_ID
100000128321
Created by admin on Fri Dec 15 20:03:47 GMT 2023 , Edited by admin on Fri Dec 15 20:03:47 GMT 2023
PRIMARY
EPA CompTox
DTXSID80203951
Created by admin on Fri Dec 15 20:03:47 GMT 2023 , Edited by admin on Fri Dec 15 20:03:47 GMT 2023
PRIMARY
RXCUI
1363444
Created by admin on Fri Dec 15 20:03:47 GMT 2023 , Edited by admin on Fri Dec 15 20:03:47 GMT 2023
PRIMARY RxNorm
DAILYMED
GIN46U9Q2Q
Created by admin on Fri Dec 15 20:03:47 GMT 2023 , Edited by admin on Fri Dec 15 20:03:47 GMT 2023
PRIMARY
CAS
554-62-1
Created by admin on Fri Dec 15 20:03:47 GMT 2023 , Edited by admin on Fri Dec 15 20:03:47 GMT 2023
PRIMARY
EVMPD
SUB35223
Created by admin on Fri Dec 15 20:03:47 GMT 2023 , Edited by admin on Fri Dec 15 20:03:47 GMT 2023
PRIMARY
FDA UNII
GIN46U9Q2Q
Created by admin on Fri Dec 15 20:03:47 GMT 2023 , Edited by admin on Fri Dec 15 20:03:47 GMT 2023
PRIMARY